Skip to main content
SpringerLink
Log in

Medikamentöse Therapie

  • Chapter
Tumorschmerztherapie

  • 78 Accesses

Zusammenfassung

Etwa 50–80% der Tumorpatienten leiden je nach Verlauf der Erkrankung unter krankheitsbedingten, oft starken Schmerzen. Dabei ist die Intensität der Schmerzen kein Maß für das Stadium der Krankheit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Agency of Health Care Policy and Research (AHCPR) (1994) Management of cancer pain. Clinical practice guideline no. 9. U.S. Department of Health and Human Services, Public Health Service, AHCPR, Publication March No.94–0592

    Google Scholar 

  • Ahmedzai S, Brooks D, on behalf on the TTS-Fentanyl Comparative Trial Group (1997) Transdermal fentanyl vs. sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life. J Pain Symptom Manage 13: 254–261

    Article  PubMed  CAS  Google Scholar 

  • Björkmann R, Ullmann A, HednerJ (1993) Morphine-sparing effect of diclofenac in cancer pain. Eur J Clin Pharmacol 44: 1–5

    Article  Google Scholar 

  • Body JJ, Bartl R, Burckhardt P et al. for the International Bone and Cancer Study Group (1998) Current use of bisphosphonates in oncology. J Clin Oncol 16/12: 3890–3899

    Google Scholar 

  • Brickenkamp R (1994) Test d2, Aufmerksamkeits-BelastungsTest, 8. Aufl. Hofgrefe, Göttingen

    Google Scholar 

  • Bromm B, Herrmann WM, Scharein E (1989) Comparison of the action of 2 effective analgetica. Experimental study: tramadol vs. tilidine/naloxone. Fortschr Med 107:385–389

    PubMed  CAS  Google Scholar 

  • Bruera E, Belzile M, Pituskin E et al. (1998) Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 16/10:3222–3229

    Google Scholar 

  • Bruera E, Roca E, Cedaro, Carraro S, Chacon R (1985) Action of oral methylprednisolone in terminal cancer patients:a prospective randomized double-blind study. Cancer Treat Rep 69:751–754

    PubMed  CAS  Google Scholar 

  • Bruera E, Sloan P, Mount B, Scott J, Suarez-Almazor for the Canadian Palliative Care Clinical Trials Group (1996) A randomized, double-blind, double-dummy, crossover trial comparing the safety an efficacy of oral sustained-release hydromorphine with immediate-release hydromorphine in patients with cancer pain. J Clin Oncol 14/5: 1713–1717

    Google Scholar 

  • Campell FA et al. (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systemic review. Brit Med J 323:13–16

    Article  Google Scholar 

  • DIVS (Deutsche Interdisziplinäre Vereinigung für Schmerztherapie) (1999) Leitlinien zur Tumorschmerztherapie. Tumordiagn Ther 20: 105–129

    Google Scholar 

  • Donner B, Strumpf M, Dertwinkel R, Zenz M (1997) Richtige Anwendung von Fentanyl TTS entscheidend. Dsch Ärztebl 94: A-598–599

    Google Scholar 

  • Ettinger AB, Portenoy RK (1988) The use of corticosteroids in the treatment of symptoms associated with cancer. J Pain Symptom Manage 3:99–103

    Article  PubMed  CAS  Google Scholar 

  • Expert Working Group of the European Association for Palliative Care (1996) Morphine in cancer pain: modes ofadministration. BMJ 312: 823–826

    Article  Google Scholar 

  • Feuerstein TJ (1997) Antidepressiva zur Therapie chronischer Schmerzen. Metaanalyse. Schmerz 3: 1–13

    Google Scholar 

  • Fromique O, Siwek B, Body JJ (1999) Bisphosphonates inhibit breast cancer call proliferation. Calf Tissue Int 64 (Suppl 1) Abstr No P261, p115

    Google Scholar 

  • Fulfaro F, Casuccio A, Ticozzi C, Ripmonti C (1998) The role of bisphosphonates in thetreatment of painful metastatic bone disease: a review of phase III trials. Pain 78/3: 157–169

    Article  Google Scholar 

  • Grond S, Radbruch L, Neuser T, Sabatowski R, Loik G, Lehmann KA (1999) Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79/1:15–20

    Article  Google Scholar 

  • Grond S, Zech DFJ, Lyncht, Radbruch L, Meuser T, Lehmann KA (1992) Validation of WHO-guidelines for cancer pain relief in 1339 patients. Xth World Congress of Anaesthesiologists, Den Haag, 12–19 June, A 271 (Abstract-Band)

    Google Scholar 

  • Hanekop GG, Beck D, Ensik FBN (1996) Schmerztherapie bei Tumorpatienten. Onkologe 2: 556–573

    Article  Google Scholar 

  • Hankemeier U, Herberhold D, Graff J (1990) Anästhesiologie, Intensivtherapie, Notfallmedizin. Thieme, Stuttgart

    Google Scholar 

  • Hankemeier U, SorgeJ et al. (1999) Anleitung zurTumorschmerztherapie bei Erwachsenen, 6. Aufl. DGSS-Arbeitskreis Tumorschmerz

    Google Scholar 

  • Hartmann N, Zenz M (1986) Opiate und Fahrtüchtigkeit. In: Doenicke A (Hrsg) Schmerz - Eine interdisziplinäre Herausforderung. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Harvey HA, Lipton A (1996) The role of biphosphonates in the treatment of bone metasteses - the U.S. experience. Supp Care Cancer 4/3: 213–217

    Google Scholar 

  • Henry D et al. (1996) Variability in risk of gastrointestinal complications with individual nonsteroidal anti-inflammatory drugs: Results of a collaborative meta-analysis. BMJ 312: 1563–1565

    Article  PubMed  CAS  Google Scholar 

  • Hortobagyi GN, Thericault RL et al. (1996) Efficacy of pamidronate in reducing skeletal complications in patiens with breast cancer and lytic bone metasteses. N Engl J Med 335: 1785–1791

    Article  PubMed  CAS  Google Scholar 

  • Husebo S, Klaschik E (2003) Palliativmedizin. Springer, Heidelberg Berlin New York Tokio

    Google Scholar 

  • International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia - a first report of their relation to drug use with special reference to analgesics. JAMA 256: 1749–1757

    Article  Google Scholar 

  • International Narcotics Control board, Consumption of narcotic drugs, 1998–2001

    Google Scholar 

  • Kim T, Kim J, Kim 5 (1993) Extended-release formulation of morphine for subcutaneous administration. Cancer Chemother Pharmacol 33: 187–190

    Article  PubMed  CAS  Google Scholar 

  • Kocher R (1981) Psychopharmaka bei chronischen Schmerzen. Schweiz Med Wochenschr 111: 1954–1964

    Google Scholar 

  • Koeberle D, Baccus L, Thürlimann B, Senn HJ (1999) Pamidronate treatment in patients with malignant oestolytic bone disease and pain: a prospective randomized double-blind trial. Supp Care Cancer 7/1: 21–27

    Article  Google Scholar 

  • Krempien B, Manegold C (1993) Prophylactic treatment of skeletal metasteses, tumor enduced osteolysis and hypercalcaemia in rats with the biphosphonate C12MBP. Cancer 72/1: 91–98

    Article  Google Scholar 

  • Langmann MJS et al. (1994) Risks of bleeding peptic ulcer associated with the individual non-steroidal anti-inflummatory drugs. Lancet 343: 1075–1078

    Article  Google Scholar 

  • Lehmann KA, Zech D (eds) (1991) Transdermal fentany. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Luben V, Müller H, Lobisch M, Wörz R (1994) Behandlung von Tumorschmerzen mit Flurpirtin. Ergebnisse einer Doppelblindstudie vs. Tramadol. Fortschr Med 112/19: 282–286

    Google Scholar 

  • McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA (1996) A systematic review of antidepressants in neuropathic pain. Pain 68:217–227

    Article  PubMed  CAS  Google Scholar 

  • Möller H, Flenker I (2001) Cannabis als Arzneimittel. Dtsch Apth Ztg 141:2132–2140

    Google Scholar 

  • Parris WC, Johnson BW Jr, Croghan MK et al. (1998) The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study. J Pain Symptom Mangage 16/4: 205–211

    Article  CAS  Google Scholar 

  • Portenoy RK, Hagen NA (1990) Breakthrough pain - definition, prevalence and characteristics. Pain 41: 273–281

    Article  PubMed  CAS  Google Scholar 

  • Posner JB (1987) Back pain and epidural spinal cord compression. Med Clin North Am 71: 185–205

    CAS  Google Scholar 

  • Radbruch L, Donner B, Zenz M, Sabatowski R, Grond S (1999) Ambulante Einstellung der transdermalen Tumorschmerztherapie mit Fentanyl. Dtsch Ärztebl 96: A-2026–2028

    Google Scholar 

  • Radbruch L, Zech DFJ, Grond S,Jung H, MeuserT (1994) Schmerzanalyse und -therapie beim Bronchialkarzinom. Chirug 65: 696–701

    CAS  Google Scholar 

  • Rodriguez M, Barutell C, Rull M et al. (1994) Efficacy and tolerance of oral dipyrone vs. oral morphine for cancer pain. Eur J Cancer 30 A/5: 584–587

    Google Scholar 

  • Roxane Laboratories, Inc. (1999) Physicians desk Referenc MarinolR (dronabinol) Capsules. Columbus, Ohio

    Google Scholar 

  • Saunders C, Baines M (1993) Living with dying: The management of terminal disease. Oxford University Press, Oxford

    Google Scholar 

  • Schönweiß G (1998) Dialyse-Fibel, 2. Aufl. Abakiss, Bad Kissingen Schug SA, Zech DFJ, Dörr U (1990) Cancer pain management

    Google Scholar 

  • according to WHO analgesic guidelines. J Pain Symptom Manage 5: 27–32

    Google Scholar 

  • Schwabing W (O. J.) Arzneimitteldosierung bei Niereninsuffizienz. Dosierungstabellen der Nephrologischen Klinik München-Schwabing, unterstützt von Cilag Biotech

    Google Scholar 

  • Sievert W, Stern Al, Lambert JR, Peacock T (1991) Low-dose antacids and nonsteroidal anti-inflammatory drug-induced gastropathy in humans. J Clin Gastroenterol 13 (Suppl 1): 5145–5148

    Google Scholar 

  • Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HAT, FriesJF (1996) Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 156: 1530–1536

    Article  PubMed  CAS  Google Scholar 

  • Strumpf M, Herberg KW, Willweber-Strumpf A, Dertwinkel R, Donner B, Zenz M (1999) Neue Daten zur sicherheitsrelevanten Leistungsfähigkeit bei Patienten unter chronischer Opioidtherapie. Schmerz 13: 51-S76

    Article  Google Scholar 

  • Strumpf M, Köhler A, Zenz M, Willweber-Strumpf A, Dertwinkel R, Donner B (1997) Opioide und Fahrtüchtigkeit. Schmerz 11:233–240

    Article  PubMed  CAS  Google Scholar 

  • Twycross RG (1981) Rehabilitation in terminal cancer patient. Int Rehab Med 3: 135–144

    CAS  Google Scholar 

  • Twycross RG (1982a) Ethical and clinical aspects of pain treatment in cancer patients. Acta Anaesthesiol Scand 74:83–90

    Article  CAS  Google Scholar 

  • Twycross RG (1982b) Medical treatment of chronic cancer pain. Bull Cancer 667: 209–216

    Google Scholar 

  • Twycross RG, Lack SA (1983) Symptom control in far advanced cancer: Pain relief. Pitman, London

    Google Scholar 

  • Uhlenbrock S et al. (2002) Cannabisarzneimittel und ihre Her- stellung in Apotheken. Krankenhauspharm 23: 159–164

    Google Scholar 

  • Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E (1995) Driving ability in cancer patients receiving long term morphine analgesia. Lancet 346:667–670

    Article  PubMed  CAS  Google Scholar 

  • Walsh TD (1984) Opiates and respiratory function in advanced cancer. Recent results. Cancer Res 89: 115–117

    CAS  Google Scholar 

  • Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60: 1303–1314

    Article  PubMed  CAS  Google Scholar 

  • Wong O, Chiu GL, Tsao CJ, Chang CL (1997) Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 35/1:25–32

    PubMed  CAS  Google Scholar 

  • World Health Organisation (1986) Cancer pain relief. WHO, Geneva

    Google Scholar 

  • World Health Organisation (1990) Cancer pain relief and palliative care - report of a WHO expert committee. WHO, Geneva

    Google Scholar 

  • World Health Organisation (1994) Cancer pain relief and opioid availability. WHO, Geneva

    Google Scholar 

  • WHO (1996) Cancer pain relief: with a guide to opioid availability. WHO, Geneva

    Google Scholar 

  • Yeomans ND, Swannell AJ, Walan A (1996) Direct comparison of omeprazole and misoprostol as maintenance treatment for NSAID-associated gastroduodenal ulcers, erosions an symptoms. Rheumatol Eur 25 (Suppl): 80

    Google Scholar 

  • Yeomans ND, Swannell AJ, Wilson J, Naesdal J, Hawkey O (1997) Maintenance treatment for NSAID-associated ulcers and erosions with omeprazole, misoprostol and ranitidine:The ASTRONAUT and OMNIUM trials. Am J Gastroenterol 92: 1628

    Google Scholar 

  • Yeomans N, Tulassy Z, Juhàsz L et al. (1998) A Comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. N Engl J Med 1/1: 719–726

    Article  Google Scholar 

  • Zech DFJ, Grond S, Lynch J et al. (1992) Transdermal fentanyl and initial dose-finding with patientcontrolled analgesia in cancer pain.A pilot study with 20 terminally ill cancer patients. Pain 50: 293–301

    Article  PubMed  CAS  Google Scholar 

  • Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organisation guidelines cancer pain relief. Pain 63:65–76

    Article  PubMed  CAS  Google Scholar 

  • Zech DFJ, Lehmann KA, Grond S (1994) A new treatment option for chronic cancer pain. EurJ Pall Care 1: 26–30

    Google Scholar 

Download references

Authors
  1. U. Hankemeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Krizanits
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, Intensiv- und Schmerztherapie, Ev. Johannes-Krankenhaus, Schildescher Str. 99, 33611, Bielefeld, Germany

    Ulrich B. Hankemeier

  2. Anästhesie- und Schmerzpraxis, Leineweberstr. 1, 45468, Mühlheim/Ruhr, Germany

    Franz H. Krizanits

  3. St.-Georg-Str. 2, 50859, Köln, Germany

    Karin Schüle-Hein

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hankemeier, U., Krizanits, F. (2004). Medikamentöse Therapie. In: Hankemeier, U.B., Krizanits, F.H., Schüle-Hein, K. (eds) Tumorschmerztherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18939-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18939-5_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62366-0

  • Online ISBN: 978-3-642-18939-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation